GENI Stock Analysis (Genius Sports Limited): Decoding the Recent Volatility

Key Data Snapshot

Current Price: $11.20 (as of 2025-10-30 close) Recent 52-Week Range: $6.72 - $13.73 P/E Ratio: -373.33 (vs. industry avg -586.5x) Market Sensitivity: High AI Prediction: 3-day upward bias of +1.4% to +3.9%

Price Action Breakdown

October 2025 Sell-Off

GENI entered a steep correction phase late October, dropping 8.3% from $11.73 (Oct 27) to $11.20 (Oct 30). This accelerated after a failed attempt to hold $12.77 support on Oct 29. The stock now hovers near its 52-week lows with technical indicators flashing mixed signals:

• Bullish: OBV surged 13x average volume during the decline
• Bearish: DMI confirms negative trend (-DI: 8.7 vs +DI: 8.2)
• Critical Support Zone: $11.72 psychological level aligns with Bollinger Band support

News Catalyst?

The lone headline from AccessWire highlights a genetic heart disease risk study tied to "CARDIO inCode-Score" - but this appears unrelated to Genius Sports' core business (sports data infrastructure/betting tech). The news item might be:

• A misattribution error (company operates in sports tech, not healthcare)
• A potential diversification hint (unlikely, given AI predictions haven't priced this in)
• Market reaction: 15.4% volume spike vs average on Oct 28